Non-disclosure agreements (NDAs) have faced widespread criticism in several jurisdictions for their role in silencing victims of workplace harassment.While countries such as the United States of ...

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

Andhra Pradesh Home Minister V. Anitha highlights farmer welfare initiatives, including increased financial support and technological advancements in agriculture.

NDAs are generally enforceable under South African contract law, provided they are reasonable in scope and duration, and do ...

A Sun Sentinel reader speculates about why the deputy attorney general recently spent all that time with Ghislaine Maxwell In ...

Dr. Tweezer-Zaks Transitions from the Company’s Board of Directors to Lead Medical Strategy Following Positive Phase 3 ...

Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, ...

North Carolina A&T Director of Athletics Earl M. Hilton III has named Kendall Cook as the new head coach of the Aggies ...

Discover key insights from Xenon Pharmaceuticals' Q2 2025 earnings call, including milestones in epilepsy, depression trials, and a strong cash ...

Belite Bio (BLTE) reports strong Q2 2025 progress on Tinlarebant trials for Stargardt's disease & geographic atrophy.

The FDA accepts a new drug application for vepdegestrant, a promising oral PROTAC developed by Arvinas and Pfizer, signaling ...

On Wednesday, Aug. 6, 2025, Governor Joe Lombardo signed AB 333 of the 83rd Legislative Session transferring the Nevada State ...